lobbying_activities: 1444657

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1444657	9711f0b4-9591-4200-996a-8b57c2afd968	3A	BROWN RUDNICK LLP	287895	HOSPIRA, INC.	2013	third_quarter	PHA	-- Issues relating to generic drug labeling -- S. 959: The Pharmaceutical Quality, Security and Accountability Act -- H.R. 3204: The Compounding Clarity Act	HOUSE OF REPRESENTATIVES,SENATE,White House Office	50000		0	0	2013-10-16T15:50:59.130000-04:00